Reduction in ocrelizumab-induced infusion reactions by a modified premedication protocol
Author:
Publisher
Elsevier BV
Subject
Neurology (clinical),Neurology,General Medicine
Reference16 articles.
1. The ageing B cell population: composition and function;Ademokun;Biogerontology,2010
2. Inflammation-induced formation of fat-associated lymphoid clusters;Bénézech;Nat. Immunol.,2015
3. Altered memory B-cell homeostasis in human aging;Breitbart;J. Gerontol. A. Biol. Sci. Med. Sci.,2002
4. Prevention and management of infusion-associated reactions in the comparison of alemtuzumab and rebif ® efficacy in multiple sclerosis (CARE-MS) program;Caon;Int. J. MS Care,2015
5. CD27(+) (memory) B cell decrease and apoptosis-resistant CD27(-) (naive) B cell increase in aged humans: implications for age-related peripheral B cell developmental disturbances;Chong;Int. Immunol.,2005
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Comparing the Risk of Infusion-Related Reactions and Tolerability in Patients Given Cetirizine or Diphenhydramine Prior to Ocrelizumab Infusion (PRECEPT);Medicina;2024-04-19
2. Patients with infusion-related reactions on fixed-dose rituximab treatment have higher body surface area than those without infusion-related reactions in adults with frequently relapsing minimal change nephrotic syndrome: a retrospective study;Journal of Pharmaceutical Health Care and Sciences;2024-02-22
3. Analysis of Risk Factors for Infusion-Related Reactions Following Rituximab Administration in Patients with Desensitization before Renal Transplantation;Biological and Pharmaceutical Bulletin;2023-09-01
4. Derisking CD20-therapies for long-term use;Multiple Sclerosis and Related Disorders;2022-01
5. Real-world experience of ocrelizumab in multiple sclerosis in an Arab population;Journal of Drug Assessment;2021-10-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3